Pillar · Research methods
Peptide Research and Clinical Trials
Most disagreements about peptides are really disagreements about evidence quality. This hub explains how peptide research is actually conducted — preclinical models, trial phases, endpoint selection, statistical estimands — and gives a practical method for judging whether a study supports the claim being made about it.
Evidence position
Established clinical evidence
Research evidence, established clinical evidence and regulatory approval are three different things. This page distinguishes them throughout and does not present research compounds as approved treatments.
The pipeline, in order
In-vitro work establishes that a molecule binds a target and produces a cellular effect. Animal work establishes whether that effect occurs in an intact organism and provides preliminary toxicology. Phase 1 human trials assess safety and pharmacokinetics, usually in small healthy cohorts. Phase 2 examines whether an effect occurs and at what exposure. Phase 3 tests that effect against a comparator in a population large enough to detect meaningful differences and uncommon harms.
Compounds fail at every stage. The attrition rate from promising animal data to demonstrated human benefit is high enough that animal results should be treated as hypotheses, not previews.
Endpoints and surrogates
A surrogate endpoint is a measurement used in place of the outcome that actually matters — a biomarker instead of a clinical event. Surrogates make trials faster and cheaper, and they have repeatedly misled entire fields. When a peptide study reports biomarker change, that is what it demonstrated; the clinical inference is a separate, unproven step.
Reading a study critically
Ask five questions: what species, what sample size, was there a control group and was allocation randomised, was the primary endpoint pre-registered, and was the material used properly characterised. A study that fails several of these can still be interesting, but it cannot carry a strong conclusion.
Key takeaways
- Most disagreements about peptides are really disagreements about evidence quality. This hub explains how peptide research is actually conducted — preclinical models, trial phases, endpoint selection, statistical estimands — and gives a practical method for judging whether a study supports the claim being made about it.
- Overall evidence position for this topic: established clinical evidence.
- Findings in cells or animals are hypotheses about humans, never demonstrations in humans.
- Nothing on this page is medical advice, a protocol, or a dosing recommendation.
Frequently asked questions
What is the strongest form of peptide evidence?
A systematic review or meta-analysis of randomised controlled trials in humans. Below that, individual randomised trials, then other human studies, then animal work, then cell work.
Why do animal results so often fail in humans?
Species differences in receptor distribution, metabolism and disease modelling, plus the fact that animal models are standardised in ways real clinical populations are not.
Continue reading
Related research hubs
Peptide Science
How peptides are built, how they signal, how they are synthesised and how they are studied — the foundational science behind every other topic on this site.
Peptide Safety
What is actually known about peptide safety — immunogenicity, contamination, unknown long-term profiles, and why absence of reported harm is not evidence of safety.
Peptide Regulation
How peptides are regulated worldwide — approved medicines versus research chemicals, FDA and EMA frameworks, compounding rules and anti-doping status.
Latest Peptide Research
Where peptide science is moving now — multi-receptor metabolic agonists, oral delivery, mitochondrial signalling and AI-assisted peptide design.
About this page
Written and reviewed by the Peptide Intel Hub Editorial Team. Last reviewed 8 September 2026.
Scientific disclaimer: this page is educational and does not constitute medical advice. Research compounds referenced here are not approved treatments. See our research disclaimer.